Le Lézard3h
Semaglutide 2.4 mg reduces burden of total cardiovascular events in people with established cardiovascular disease and overweight or obesity
A new sub-analysis of the SELECT trial data shows semaglutide 2.4 mg substantially reduces the burden of total cardiovascular events in people with established CVD and overweight or obesity without ...
EMBO Press2h
HAND1 level controls the specification of multipotent cardiac and extraembryonic progenitors from human pluripotent stem cells
How cardiac cell fates are specified during heart development remains elusive. This study identifies a level-dependent role ...
BMJ12h
Recognition, assessment and management of the mechanical complications of acute myocardial infarction
Understand the underlying mechanisms of mechanical complications after acute myocardial infarction (AMI). Recognise the possibility and the importance of mechanical complications after AMI and ...